The court found Actavis and co-defendant Actavis Elizabeth to have misrepresented its drug prices to Medicaid.
The decision came after Florida-based pharmacy Ven-a-Care filed a whistleblower lawsuit under seal against Actavis.
The pharmacy owners said Actavis had reported artificially inflated prices to Medicaid for its drugs.